↓ Skip to main content

A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Overview of attention for article published in BMC Infectious Diseases, November 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
106 Mendeley
Title
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome
Published in
BMC Infectious Diseases, November 2016
DOI 10.1186/s12879-016-1979-z
Pubmed ID
Authors

Claudia M. D. de Maio Carrilho, Larissa Marques de Oliveira, Juliana Gaudereto, Jamile S. Perozin, Mariana Ragassi Urbano, Carlos H. Camargo, Cintia M. C. Grion, Anna Sara S. Levin, Silvia F. Costa

Abstract

To describe the clinical and microbiological data of carbapenem-resistant Enterobacteriaceae (CRE) infections, the treatment used, hospital- and infection-related mortality, and risk factors for death. A prospective cohort conducted from March 2011 to December 2012. Clinical, demographic, and microbiological data such as in vitro sensitivity, clonality, carbapenemase gene mortality related to infection, and overall mortality were evaluated. Data were analyzed using Epi Info version 7.0 (CDC, Atlanta, GA, USA) and SPSS (Chicago, IL, USA). One hundred and twenty-seven patients were evaluated. Pneumonia, 52 (42 %), and urinary tract infections (UTI), 51 (40.2 %), were the most frequent sites of infection. The isolates were polyclonal; the Bla KPC gene was found in 75.6 % of isolates, and 27 % of isolates were resistant to colistin. Mortality related to infection was 34.6 %, and was higher among patients with pneumonia (61.4 %). Combination therapy was used in 98 (77.2 %), and monotherapy in 22.8 %; 96.5 % of them were UTI patients. Shock, age, and dialysis were independent risk factors for death. There was no difference in infection-related death comparing colistin-susceptible and colistin-resistant infections (p = 0.46); neither in survival rate comparing the use of combination therapy with two drugs or more than two drugs (p = 0.32). CRE infection mortality was higher among patients with pneumonia. Infections caused by colistin-resistant isolates did not increase mortality. The use of more than two drugs on combination therapy did not show a protective effect on outcome. The isolates were polyclonal, and the bla KPC gene was the only carbapenemase found. Shock, dialysis, and age over 60 years were independent risk factors for death.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 12%
Student > Master 13 12%
Student > Bachelor 13 12%
Student > Doctoral Student 10 9%
Student > Postgraduate 9 8%
Other 23 22%
Unknown 25 24%
Readers by discipline Count As %
Medicine and Dentistry 35 33%
Immunology and Microbiology 9 8%
Biochemistry, Genetics and Molecular Biology 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Agricultural and Biological Sciences 4 4%
Other 13 12%
Unknown 34 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2016.
All research outputs
#13,122,093
of 22,899,952 outputs
Outputs from BMC Infectious Diseases
#3,117
of 7,691 outputs
Outputs of similar age
#157,172
of 311,569 outputs
Outputs of similar age from BMC Infectious Diseases
#94
of 231 outputs
Altmetric has tracked 22,899,952 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,691 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,569 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 231 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.